The cost of ACT as well as the limits of existing supplies are key areas where donors, agencies and governments could potentially make a real difference.
Unfortunately, until now, in terms of articulated policy the donors have fallen into two camps. The US and the UK, the "go slow" countries, which have spent considerable energy chronicling the barriers to ACT introduction, suggest "leaving alone" current protocols whenever possible;
"In poor countries like ours, children have only one chance. They struggle just to visit a health service, and if they get the wrong drug the first time, they are then found dead."
Dr. Fred Binka, professor of epidemiology, University of Ghana